CIK: 0001596452
Total reported value
$131.7M
Reporting period: 2026-03-31 · Number of holdings: 34
Sivik Global Healthcare LLC disclosed 34 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $131.7M and a quarterly turnover rate of 111.6%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "S"
Sivik Global Healthcare LLC's disclosed holdings carry a Herfindahl concentration index of 0.045 — mathematically equivalent to about 22 equally-sized positions, close to its 34 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.75), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Add XBI
-33.3% -$8.3M
Add MRK
+33.3% $1.7M
Add CAH
-26.2% -$1.6M
Add COR
-16.7% -$1.4M
Add VRTX
-27.4% -$1.8M
Add ISRG
-10.0% -$1.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 14.55% | +6.59% | -33.33% | |
| 2 | CAH | Cardinal Health INC | Stock-Healthcare | 3.85% | +1.91% | -26.15% | |
| 3 | ✓ | Call- Bsx 100 @ 75 Exp 04/17/2026 | Stock-Other | 3.81% | +3.81% | NEW | |
| 4 | JNJ | Johnson & Johnson | Stock-Healthcare | 3.71% | +3.71% | NEW | |
| 5 | MRK | Merck & Co. INC. | Stock-Healthcare | 3.65% | +2.73% | +33.33% | |
| 6 | COR | Cencora INC | Stock-Healthcare | 3.58% | +1.82% | -16.67% | |
| 7 | LLY | Eli Lilly & Co | Stock-Healthcare | 3.49% | +1.31% | -28.57% | |
| 8 | WAT | Waters CORP | Stock-Healthcare | 3.39% | +3.39% | NEW | |
| 9 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 3.39% | +1.58% | -27.38% | |
| 10 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 3.15% | +1.51% | -10.00% | |
| 11 | AZN | AstraZeneca PLC | Stock-Healthcare | 3.00% | +3.00% | NEW | |
| 12 | TMO | Thermo Fisher Scientific INC | Stock-Healthcare | 2.99% | +0.97% | -33.33% | |
| 13 | BSX | Boston Scientific CORP | Stock-Healthcare | 2.95% | +1.01% | -11.43% | |
| 14 | DHR | Danaher CORP | Stock-Healthcare | 2.88% | +1.35% | -13.04% | |
| 15 | THC | Tenet Healthcare CORP | Stock-Healthcare | 2.87% | +0.71% | -46.67% | |
| 16 | GILD | Gilead Sciences INC | Stock-Healthcare | 2.65% | — | — | |
| 17 | HUM | Humana INC | Stock-Healthcare | 2.63% | — | +33.33% | |
| 18 | MTD | Mettler-toledo International | Stock-Healthcare | 2.63% | — | -8.33% | |
| 19 | MCK | Mckesson CORP | Stock-Healthcare | 2.63% | +0.49% | -55.56% | |
| 20 | A | Agilent Technologies INC | Stock-Healthcare | 2.60% | +1.22% | -14.29% | |
| 21 | SYK | Stryker CORP | Stock-Healthcare | 2.50% | +1.17% | -23.08% | |
| 22 | ABBV | Abbvie INC | Stock-Healthcare | 2.48% | +1.15% | -25.00% | |
| 23 | UHS | Universal Health Services-b | Stock-Healthcare | 2.38% | +0.61% | -37.50% | |
| 24 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 2.35% | +2.35% | NEW | |
| 25 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 2.12% | — | -16.67% | |
| 26 | BIIB | Biogen INC | Stock-Healthcare | 2.09% | — | -25.00% | |
| 27 | UNH | Unitedhealth Group INC | Stock-Healthcare | 2.05% | +0.90% | -16.67% | |
| 28 | GMED | Globus Medical INC - A | Stock-Healthcare | 1.96% | — | -25.00% | |
| 29 | ABT | Abbott Laboratories | Stock-Healthcare | 1.95% | +0.50% | -37.50% | |
| 30 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.22% | +0.35% | -42.86% | |
| 31 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 1.21% | +0.02% | -60.00% | |
| 32 | ELV | Elevance Health INC | Stock-Healthcare | 1.11% | +1.11% | NEW | |
| 33 | EHC | Encompass Health CORP | Stock-Healthcare | 1.10% | -0.44% | -70.00% | |
| 34 | CVS | Cvs Health CORP | Stock-Healthcare | 1.09% | +1.09% | NEW |
Performance for Q3 2026
+8.6%
Performance Last 4 Quarters
+16%
Based on 66% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 34 | $131.7M | 100 | |
| 2025-12-31 | 49 | $344.6M | 100 | |
| 2025-09-30 | 44 | $343.7M | 74 | |
| 2025-06-30 | 46 | $367.6M | 0 | |
| 2025-03-31 | 31 | $185.0M | 100 | |
| 2024-12-31 | 38 | $189.9M | 0 | |
| 2024-09-30 | 35 | $236.2M | 0 | |
| 2024-06-30 | 38 | $278.4M | 0 | |
| 2024-03-31 | 47 | $426.6M | 0 | |
| 2023-12-31 | 39 | $239.4M | 0 | |
| 2023-09-30 | 33 | $197.9M | 0 | |
| 2023-06-30 | 43 | $427.5M | 0 | |
| 2023-03-31 | 40 | $232.6M | 0 | |
| 2022-12-31 | 39 | $212.7M | 0 | |
| 2022-09-30 | 41 | $179.9M | 0 | |
| 2022-06-30 | 38 | $176.0M | 0 | |
| 2022-03-31 | 49 | $242.3M | 0 | |
| 2021-12-31 | 45 | $233.4M | 0 | |
| 2021-09-30 | 43 | $418.5M | 0 | |
| 2021-06-30 | 49 | $512.0M | 70 | |
| 2021-03-31 | 47 | $274.2M | 66 | |
| 2020-12-31 | 38 | $245.3M | 52 | |
| 2020-09-30 | 38 | $232.5M | 100 | |
| 2020-06-30 | 52 | $301.9M | 80 | |
| 2020-03-31 | 40 | $253.4M | 87 | |
| 2019-12-31 | 50 | $269.4M | 59 | |
| 2019-09-30 | 45 | $198.2M | 94 | |
| 2019-06-30 | 62 | $413.6M | 90 | |
| 2019-03-31 | 61 | $271.4M | 66 | |
| 2018-12-31 | 48 | $185.5M | 69 | |
| 2018-09-30 | 63 | $280.2M | 53 | |
| 2018-06-30 | 63 | $260.1M | 69 | |
| 2018-03-31 | 59 | $214.3M | 64 | |
| 2017-12-31 | 69 | $269.4M | 69 | |
| 2017-09-30 | 78 | $293.9M | 56 | |
| 2017-06-30 | 68 | $273.2M | 57 | |
| 2017-03-31 | 59 | $214.7M | 67 | |
| 2016-12-31 | 56 | $209.6M | 74 | |
| 2016-09-30 | 54 | $198.3M | 77 | |
| 2016-06-30 | 60 | $201.2M | 76 | |
| 2016-03-31 | 58 | $225.9M | 67 | |
| 2015-12-31 | 60 | $210.6M | 60 | |
| 2015-09-30 | 57 | $206.2M | 58 | |
| 2015-06-30 | 69 | $288.2M | 58 | |
| 2015-03-31 | 75 | $293.9M | 52 | |
| 2014-12-31 | 63 | $246.9M | 57 | |
| 2014-09-30 | 69 | $220.0M | 51 | |
| 2014-06-30 | 70 | $198.1M | 59 | |
| 2014-03-31 | 66 | $160.2M | 60 | |
| 2013-12-31 | 57 | $140.7M | 0 |
Sivik Global Healthcare LLC's most significant position changes for 2026-03-31: Sold out: Put - Spy 100 @ 684 Exp 01/30/2026; Sold out: Put - Spy 100 @ 679 Exp 01/30/2026; Sold out: ; Sold out: ; Sold out: Put - Spy 100 @ 682 Exp 02/20/2026.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +6.6% | -33.33% | Trim |
| 2 | MRK | Merck & Co. INC. | +2.7% | +33.33% | Add |
| 3 | CAH | Cardinal Health INC | +1.9% | -26.15% | Trim |
| 4 | COR | Cencora INC | +1.8% | -16.67% | Trim |
| 5 | VRTX | Vertex Pharmaceuticals INC | +1.6% | -27.38% | Trim |
| 6 | ISRG | Intuitive Surgical INC | +1.5% | -10.00% | Trim |
| 7 | DHR | Danaher CORP | +1.4% | -13.04% | Trim |
| 8 | LLY | Eli Lilly & Co | +1.3% | -28.57% | Trim |
| 9 | A | Agilent Technologies INC | +1.2% | -14.29% | Trim |
| 10 | SYK | Stryker CORP | +1.2% | -23.08% | Trim |
| 11 | ABBV | Abbvie INC | +1.2% | -25.00% | Trim |
| 12 | BSX | Boston Scientific CORP | +1% | -11.43% | Trim |
| 13 | TMO | Thermo Fisher Scientific INC | +1% | -33.33% | Trim |
| 14 | UNH | Unitedhealth Group INC | +0.9% | -16.67% | Trim |
| 15 | THC | Tenet Healthcare CORP | +0.7% | -46.67% | Trim |
| 16 | UHS | Universal Health Services-b | +0.6% | -37.50% | Trim |
| 17 | ABT | Abbott Laboratories | +0.5% | -37.50% | Trim |
| 18 | MCK | Mckesson CORP | +0.5% | -55.56% | Trim |
| 19 | EW | Edwards Lifesciences CORP | +0.4% | -42.86% | Trim |
| 20 | SNN | Smith & Nephew PLC -spon Adr | 0% | -60.00% | Trim |
| 21 | EHC | Encompass Health CORP | -0.4% | -70.00% | Trim |
| 22 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | — | EXIT | Sold out |
| 23 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | — | EXIT | Sold out |
| 24 | ✓ | — | EXIT | Sold out | |
| 25 | ✓ | — | EXIT | Sold out | |
| 26 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | — | EXIT | Sold out |
| 27 | ✓ | — | EXIT | Sold out | |
| 28 | ✓ | — | EXIT | Sold out | |
| 29 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | — | EXIT | Sold out |
| 30 | HCA | Hca Healthcare INC | — | EXIT | Sold out |
| 31 | ✓ | Call- Bsx 100 @ 75 Exp 04/17/2026 | — | NEW | New buy |
| 32 | JNJ | Johnson & Johnson | — | NEW | New buy |
| 33 | WAT | Waters CORP | — | NEW | New buy |
| 34 | MDT | Medtronic plc | — | EXIT | Sold out |
| 35 | RGEN | Repligen CORP | — | EXIT | Sold out |
| 36 | AZN | AstraZeneca PLC | — | NEW | New buy |
| 37 | BDX | Becton Dickinson And Co | — | EXIT | Sold out |
| 38 | NVO | Novo-nordisk A/s-spons Adr | — | EXIT | Sold out |
| 39 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | Sold out |
| 40 | REGN | Regeneron Pharmaceuticals | — | NEW | New buy |
| 41 | SGRY | Surgery Partners INC | — | EXIT | Sold out |
| 42 | BRKR | Bruker CORP | — | EXIT | Sold out |
| 43 | GEHC | GE Healthcare Technology | — | EXIT | Sold out |
| 44 | SEM | Select Medical Holdings CORP | — | EXIT | Sold out |
| 45 | TECH | Bio-techne CORP | — | EXIT | Sold out |
| 46 | ELV | Elevance Health INC | — | NEW | New buy |
| 47 | CGON | Cg Oncology INC | — | EXIT | Sold out |
| 48 | CVS | Cvs Health CORP | — | NEW | New buy |
| 49 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |
| 50 | ALNY | Alnylam Pharmaceuticals INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-04-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-01-21 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-10-23 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-07-25 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-04-22 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-01-23 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-06 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-07-29 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-01 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-05 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-07 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-09 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-08 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-08 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-04 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-10 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-09 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-08 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-10 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-12 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-13 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-12 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-08 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-12 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-13 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-06 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-08 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-08 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-08 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-11 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-11 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-13 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-05 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-06 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-05 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-04 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-07-06 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-04-01 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-01-07 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-10-03 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-07-03 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-04-10 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-01-10 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002107563
Total reported value
$131.7M
25 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002045268
Total reported value
$131.7M
85 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001709478
Total reported value
$131.7M
1 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000886920
Total reported value
$351.1M
113 stks
2015-03-31
Stale — no recent filing
2 of the top 5 holdings overlap, including Johnson & Johnson
CIK 0000938759
Total reported value
$408.6M
127 stks
2026-03-31
2 of the top 5 holdings overlap, including Merck & Co. INC.
CIK 0001127544
Total reported value
$318.8M
117 stks
2024-06-30
Stale — no recent filing
2 of the top 5 holdings overlap, including Johnson & Johnson